InsidersTradesSigma
Track the 日本新薬株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Banks sector, 日本新薬株式会社 has logged 8 insider filings. Market capitalisation: €40,641.8bn. The latest transaction was reported on 6 August 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. All data is openly available.
Analysts rate 日本新薬株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,619.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
日本新薬株式会社 是一家在日本金融和银行领域运营的日本公司。它在东京证券交易所（XTKS）上市。